Literature DB >> 24997695

Diffuse glutamine synthetase overexpression restricted to areas of peliosis in a β-catenin-activated hepatocellular adenoma: a potential pitfall in glutamine synthetase interpretation.

Ryan S Berry1, Rama R Gullapalli, Jin Wu, Katherine Morris, Joshua A Hanson.   

Abstract

Hepatocellular adenomas have recently been classified into four subtypes based on molecular findings: hepatocyte nuclear factor 1α (HNF1α) inactivated, inflammatory/telangiectatic, β-catenin activated, and unclassifiable. β-catenin-activated adenomas have the potential for malignant transformation and are thus important to recognize. Diffuse glutamine synthetase immunohistochemical positivity has been shown to be a reliable surrogate marker for β-catenin activation, though variations in staining patterns may be difficult to interpret. We report a case of a peliotic adenoma that was morphologically consistent with a β-catenin wild-type hepatocellular adenoma but harbored a β-catenin mutation by molecular analysis. The tumor lacked nuclear β-catenin positivity and demonstrated a hitherto undescribed pattern of glutamine synthetase overexpression restricted to areas of peliosis with mostly negative staining in non-peliotic areas. This pattern was initially interpreted as physiologic and may represent a potential pitfall in glutamine synthetase interpretation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24997695     DOI: 10.1007/s00428-014-1620-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  10 in total

1.  Revisiting the pathology of resected benign hepatocellular nodules using new immunohistochemical markers.

Authors:  Paulette Bioulac-Sage; Gaelle Cubel; Charles Balabaud; Jessica Zucman-Rossi
Journal:  Semin Liver Dis       Date:  2011-02-22       Impact factor: 6.115

2.  Reduction and expansion of the glutamine synthetase expressing zone in livers from tetracycline controlled TGF-beta1 transgenic mice and multiple starved mice.

Authors:  Elke Ueberham; Elisabeth Arendt; Michael Starke; Renate Bittner; Rolf Gebhardt
Journal:  J Hepatol       Date:  2004-07       Impact factor: 25.083

3.  Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.

Authors:  Paulette Bioulac-Sage; Gaelle Cubel; Saïd Taouji; Jean-Yves Scoazec; Emmanuelle Leteurtre; Valérie Paradis; Nathalie Sturm; Jeanne Tran Van Nhieu; Dominique Wendum; Brigitte Bancel; Jeanne Ramos; François Paraf; Marie Christine Saint Paul; Sophie Michalak; Monique Fabre; Catherine Guettier; Brigitte Le Bail; Jessica Zucman-Rossi; Charles Balabaud
Journal:  Am J Surg Pathol       Date:  2012-11       Impact factor: 6.394

4.  Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC.

Authors:  Jessica Zucman-Rossi; Emmanuelle Jeannot; Jeanne Tran Van Nhieu; Jean-Yves Scoazec; Catherine Guettier; Sandra Rebouissou; Yannick Bacq; Emmanuelle Leteurtre; Valérie Paradis; Sophie Michalak; Dominique Wendum; Laurence Chiche; Monique Fabre; Lucille Mellottee; Christophe Laurent; Christian Partensky; Denis Castaing; Elie Serge Zafrani; Pierre Laurent-Puig; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

5.  Perflubron emulsion in prolonged hemorrhagic shock: influence on hepatocellular energy metabolism and oxygen-dependent gene expression.

Authors:  Markus Paxian; Hauke Rensing; Katrin Geckeis; Inge Bauer; Darius Kubulus; Donat R Spahn; Michael Bauer
Journal:  Anesthesiology       Date:  2003-06       Impact factor: 7.892

6.  Hepatocellular adenoma subtype classification using molecular markers and immunohistochemistry.

Authors:  Paulette Bioulac-Sage; Sandra Rebouissou; Cristel Thomas; Jean-Frédéric Blanc; Jean Saric; Antonio Sa Cunha; Anne Rullier; Gaëlle Cubel; Gabrielle Couchy; Sandrine Imbeaud; Charles Balabaud; Jessica Zucman-Rossi
Journal:  Hepatology       Date:  2007-09       Impact factor: 17.425

Review 7.  Hepatocellular expression of glutamine synthetase: an indicator of morphogen actions as master regulators of zonation in adult liver.

Authors:  Rolf Gebhardt; Alicja Baldysiak-Figiel; Vera Krügel; Elke Ueberham; Frank Gaunitz
Journal:  Prog Histochem Cytochem       Date:  2007-02-08

8.  Hepatocellular adenoma management and phenotypic classification: the Bordeaux experience.

Authors:  Paulette Bioulac-Sage; Hervé Laumonier; Gabrielle Couchy; Brigitte Le Bail; Antonio Sa Cunha; Anne Rullier; Christophe Laurent; Jean-Frédéric Blanc; Gaelle Cubel; Hervé Trillaud; Jessica Zucman-Rossi; Charles Balabaud; Jean Saric
Journal:  Hepatology       Date:  2009-08       Impact factor: 17.425

9.  Value and limits of routine histology alone or combined with glutamine synthetase immunostaining in the diagnosis of hepatocellular adenoma subtypes on surgical specimens.

Authors:  Paulette Bioulac-Sage; Saïd Taouji; Brigitte Le Bail; Laurent Possenti; Charles Balabaud
Journal:  Int J Hepatol       Date:  2013-02-19

10.  Correlation between beta-catenin mutations and expression of Wnt-signaling target genes in hepatocellular carcinoma.

Authors:  Madeleine Austinat; Ruediger Dunsch; Christian Wittekind; Andrea Tannapfel; Rolf Gebhardt; Frank Gaunitz
Journal:  Mol Cancer       Date:  2008-02-18       Impact factor: 27.401

  10 in total
  4 in total

1.  Authors' response.

Authors:  Ryan S Berry; Joshua A Hanson
Journal:  Virchows Arch       Date:  2014-08-23       Impact factor: 4.064

2.  Glutamine synthetase interpretation in hepatocellular adenoma.

Authors:  Charles Balabaud; Paulette Bioulac-Sage
Journal:  Virchows Arch       Date:  2014-09-13       Impact factor: 4.064

3.  Hepatocellular adenoma classification: a comparative evaluation of immunohistochemistry and targeted mutational analysis.

Authors:  Elizabeth Margolskee; Fei Bao; Anne Koehne de Gonzalez; Roger K Moreira; Stephen Lagana; Anthony N Sireci; Antonia R Sepulveda; Helen Remotti; Jay H Lefkowitch; Marcela Salomao
Journal:  Diagn Pathol       Date:  2016-03-09       Impact factor: 2.644

4.  Correlation of exon 3 β-catenin mutations with glutamine synthetase staining patterns in hepatocellular adenoma and hepatocellular carcinoma.

Authors:  Gillian Hale; Xinxin Liu; Junjie Hu; Zhong Xu; Li Che; David Solomon; Christos Tsokos; Nafis Shafizadeh; Xin Chen; Ryan Gill; Sanjay Kakar
Journal:  Mod Pathol       Date:  2016-07-29       Impact factor: 7.842

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.